HIGHLIGHTS
- who: Grace Kong from the Department of Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia have published the paper: Integrating Functional Imaging and Molecular Profiling for Optimal Treatment Selection in Neuroendocrine Neoplasms (NEN), in the Journal: (JOURNAL)
- what: We are in an exciting era for the biological interrogation of neuroendocrine neoplasms to guide precision management by incorporating molecular imaging assessment with clinically relevant molecular pathology pathway and genomic evaluation.
- future: Its benefits warrant further prospective validation to enable integration in NEN management. It is also imperative . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.